← All Sponsors

SPONSOR

Marengo Therapeutics, Inc.

Total Trials

1

Recruiting

1

Phases

Phase 1, Phase 2

Conditions studied: Advanced Solid Tumors Genital Neoplasm, Female Urogenital Neoplasms Lung Neoplasm Neoplasms by Site Papillomavirus Infection Epstein-Barr Virus Infections Carcinoma Neoplasms Vulvar Neoplasms

NCT05592626 Phase 1, Phase 2

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Advanced Solid Tumors